HBCM
IMNM icon

Heron Bay Capital Management’s Immunome IMNM Stock Holding History

Heron Bay Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,139
Closed -$104K – 106
2023
Q2 		$104K Buy
+13,139
New +$71.9K 0.03% 78

Other funds holding IMNM

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Heron Bay Capital Management's IMNM Position: Q3 2023 in Review

Heron Bay Capital Management sold out of Immunome (IMNM) in Q3 2023, closing a stake of 13,139 shares — an estimated $104K sold.

Heron Bay Capital Management first reported a position in IMNM in Q2 2023 and held it in 1 quarter. The position peaked at $104K in Q2 2023. 35 funds tracked by Wall St. Rank hold IMNM as of Q3 2023.

  • Heron Bay Capital Management reported no remaining Immunome position as of Q3 2023 after selling out during the quarter.
  • Heron Bay Capital Management sold 13,139 Immunome shares in Q3 2023, an estimated $104K.
  • Heron Bay Capital Management first reported a position in Immunome in Q2 2023 and held it in 1 quarter.
  • Heron Bay Capital Management's Immunome position peaked at $104K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held Immunome as of Q3 2023.

Based on Heron Bay Capital Management's 13F filing for Q3 2023, filed 1 Nov 2023.